Company Ticker News October 14, 2021Regeneron is seeking full FDA approval for its monoclonal antibody for two types of COVID-19 patients 0 0 Share
Press Release October 14, 2021FDA Accepts REGEN-COV® (casirivimab and imdevimab) for Priority Review for Treatment and Prophylaxis of COVID-19 0 0 Share
Press Release October 13, 2021Regeneron (REGN) Outpaces Stock Market Gains: What You Should Know 0 0 Share
Company Ticker News October 11, 2021Regeneron to Report Third Quarter 2021 Financial and Operating Results and Host Conference Call and Webcast on November 4, 2021 0 0 Share
Company Ticker News October 11, 20214 Reasons to Add Regeneron (REGN) Stock to Your Portfolio 0 0 Share
Company Ticker News October 8, 20213 Reasons Why Growth Investors Shouldn't Overlook Regeneron (REGN) 0 0 Share
Company Ticker News October 5, 2021Will Regeneron (REGN) Beat Estimates Again in Its Next Earnings Report? 0 0 Share
